METHODS ELABORATION ON DETECTION OF SOME ATYPICAL NEUROLYTIC AGENTS FOR CHEMICAL AND TOXICOLOGICAL ANALYSIS
- 作者: Remezova I.1, Lazaryan D.1, Maksimenko T.1, Sanzhieva D.1, Rybasova A.1
-
隶属关系:
- Pyatigorsk Medical and Pharmaceutical Institute - branch of Volgograd State Medical University of the Ministry of Healthcare of Russia, Pyatigorsk
- 期: 卷 2, 编号 6 (2014)
- 页面: 54-58
- 栏目: Articles
- URL: https://journals.rcsi.science/2307-9266/article/view/111292
- ID: 111292
如何引用文章
全文:
详细
It is necessary to elaborate methods of atypical neuroleptic agents detection as individual substances and in different combinations as well for diagnosis of poisoning by some of them: clozapine, risperidone, sertindole, olanzapine, aripiprazole. The purpose of this work is methods elaboration of detection of clozapine, risperidone, sertindole, olanzapine, aripiprazole, haloperidol, oxazepam, carbamazapine using TLC, HPLC and UV spectrophotometry methods.During this work we used tablet forms of clozapine, risperidone, sertindole, olanzapine, aripiprazole. It is possible to use solution systems like ethanol-water-25% ammonia solution (8:1:1), toluol-acetone-ethanol-25% ammonia solution (45:45:7.5:2.5), dioxan-chloroform-acetone-25% ammonia solution (47.5:45:5:2.5) for preliminary examination of atypical neuroleptic agents under study in combination with typical neuroleptics and tranquilizers with undirected analysis (general screening). System of solvents ethyl-acetate-chloroform-25% ammonia solution (85:10:5) is recommended to use for individual screening of risperidone, sertindole, olanzapine, haloperidol, benzol-ethanol-25% ammonia solution (50:10:0.5) system to use for clozapine, sertindole, olanzapine. Ethanol-25% ammonia solution (100:1.5) system is reasonable to use for chromatographic clearance of extracts from biological substances under study. We recommend using HPLC method and UV spectrophotometry for carrying out of a principal examination of clozapine, risperidone, sertindole, olanzapine and aripiprazole in case one of the substances under study is determined in the object.
作者简介
I. Remezova
Pyatigorsk Medical and Pharmaceutical Institute - branch of Volgograd State Medical University of the Ministry of Healthcare of Russia, Pyatigorsk
Email: i.p.remezova@pmedpharm.ru
D. Lazaryan
Pyatigorsk Medical and Pharmaceutical Institute - branch of Volgograd State Medical University of the Ministry of Healthcare of Russia, Pyatigorsk
Email: j.s.lazaryan@pmedpharm.ru
T. Maksimenko
Pyatigorsk Medical and Pharmaceutical Institute - branch of Volgograd State Medical University of the Ministry of Healthcare of Russia, Pyatigorsk
D. Sanzhieva
Pyatigorsk Medical and Pharmaceutical Institute - branch of Volgograd State Medical University of the Ministry of Healthcare of Russia, Pyatigorsk
A. Rybasova
Pyatigorsk Medical and Pharmaceutical Institute - branch of Volgograd State Medical University of the Ministry of Healthcare of Russia, Pyatigorsk
参考
- Маляров С.А. Чем должен руководствоваться врач при назначении комбинированной антипсихотической терапии? [Электронный ресурс]. - Режим доступа: http://www.health-ua.org/archives/health/738.html.
- Поспелова, А.А. Оценка возможности использования обращенно-фазной тонкослойной хроматографии в химико-токсикологических исследованиях ряда групп лекарственных и химических соединениях / А.А. Поспелова, Л.Н. Карпова, Т.Л. Малкова // Токсикологический вестник. - 2012. - №2.
- Livingstone M.G. Management of schizophrenia // Prescribers J. - 1996. - № 36. - Р. 206-215.
- The use of atypical antipsychotics in the management of schizophrenia / M. Cambell [et al] // British Journal of Clinical Pharmacology. - 2000. - №6. - P. 432-438.